Oct 28, 2024, 10:54
SPCC – Brian Druker reflects on the key milestones of his life and career
SPCC (Sharing Progress in Cancer Care) shared on Linkedin:
”Have you already watched Aleksandra Filipovic’s inspirational interview with Brian Druker, the esteemed director of the OHSU Knight Cancer Institute?
Known for his groundbreaking work in cancer research, Druker developed Gleevec, a targeted therapy that revolutionised the treatment of chronic myeloid leukemia (CML) by attacking cancer cells while preserving healthy ones.
In the interview, Druker reflects on the key milestones of his life and career, from his early days to his present work.
Every new drug has a human who has championed it to existence, who persevered, who believed. Who knew the ‘Why’ and therefore found the ‘How’.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 28, 2024, 10:54
Oct 28, 2024, 10:42
Oct 28, 2024, 10:36
Oct 28, 2024, 10:07
Oct 28, 2024, 10:03
Oct 28, 2024, 09:55
Oct 28, 2024, 09:49